Mamta Madhav Shah, MD
Nephrology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: 752582 · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C182785 · Current
Licensed to practise in California · since 2022 · expires 2026-10-31 · Maharashtra University of Health Sciences, K.J. Somaiya Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$72,427
Medicare paid this office $72,427 for 238 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $18,749 | $70 |
| Dialysis procedure including 1 evaluation | 28 | $9,715 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $7,236 | $117 |
| Long return visit (40+ min) | 31 | $5,758 | $160 |
| Return visit (30+ min) | 35 | $4,921 | $123 |
See all 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $18,749 | $70 |
| Dialysis procedure including 1 evaluation | 28 | $9,715 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $7,236 | $117 |
| Long return visit (40+ min) | 31 | $5,758 | $160 |
| Return visit (30+ min) | 35 | $4,921 | $123 |
| Hemodialysis procedure with physician evaluation | 37 | $3,490 | $62 |
| New patient visit (60+ min) | 16 | $3,160 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,976 | $106 |
| New patient visit (45+ min) | 11 | $1,594 | $145 |
| Short return visit (20+ min) | 12 | $1,445 | $85 |
Who their Medicare patients are
238 Original Medicare patients in 2024. Average age 70 · Under 65 21% · 85 and older 13% · Women 49% · Also on Medicaid 46% · Health risk score 5.03. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 64% · Heart failure 53% · Coronary heart disease 49% · Atrial fibrillation 37% · Depression 26% · Cancer 23% · COPD 22% · Stroke 22% · Dementia 21%.
The office billed $355,213, Medicare allowed $91,481 and paid $72,427; for 737 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 238 | 737 | 70 | 5.03 | $355,213 | $72,427 |
| 2023 | 173 | 595 | 71 | 5.40 | $201,633 | $47,407 |
| 2022 | 141 | 576 | 70 | 5.10 | $135,865 | $55,466 |
| 2021 | 132 | 573 | 70 | 4.63 | $130,775 | $50,972 |
| 2020 | 124 | 572 | 70 | 5.52 | $93,550 | $34,004 |
| 2019 | 169 | 1,056 | 69 | 5.91 | $200,890 | $72,575 |
| 2018 | 197 | 1,037 | 69 | 5.32 | $184,860 | $71,053 |
| 2017 | 102 | 469 | 68 | 5.63 | $67,065 | $25,804 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $10,214 | $72 |
| Dialysis procedure including 1 evaluation | 13 | $6,836 | $79 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 19 | $6,002 | $300 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,651 | $118 |
| Hemodialysis procedure with physician evaluation | 23 | $2,292 | $60 |
| New patient visit (60+ min) | 14 | $2,230 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,029 | $107 |
| Return visit (30+ min) | 19 | $1,880 | $85 |
| New patient visit (45+ min) | 11 | $1,344 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $623 | $44 |
2022: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $22,854 | $305 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $6,379 | $255 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $5,306 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,771 | $60 |
| Hemodialysis procedure with physician evaluation | 19 | $2,544 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,353 | $168 |
| Return visit (30+ min) | 24 | $1,992 | $77 |
| Long return visit (40+ min) | 14 | $1,933 | $114 |
2021: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 35 | $20,497 | $306 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $5,824 | $87 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $3,066 | $256 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,718 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $1,829 | $61 |
| Hemodialysis procedure with physician evaluation | 13 | $1,800 | $62 |
| Long return visit (40+ min) | 13 | $1,758 | $126 |
| Return visit (30+ min) | 15 | $1,705 | $85 |
2020: 8 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 36 | $12,628 | $248 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 11 | $3,741 | $208 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,775 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,996 | $62 |
| Hemodialysis procedure with physician evaluation | 19 | $1,907 | $64 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,583 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $750 | $58 |
| Return visit (30+ min) | 13 | $690 | $53 |
2019: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 46 | $21,994 | $244 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $10,249 | $89 |
| Hemodialysis procedure with physician evaluation | 34 | $6,590 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,032 | $174 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 19 | $4,935 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,554 | $62 |
| Dialysis services, per day, less than full month service (20 years or older) | 18 | $2,976 | $7 |
| Long return visit (40+ min) | 16 | $2,925 | $91 |
| Return visit (30+ min) | 30 | $2,188 | $53 |
| New patient visit (60+ min) | 11 | $1,240 | $113 |
2018: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $16,748 | $239 |
| Hemodialysis procedure with physician evaluation | 52 | $8,141 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $8,117 | $61 |
| Home dialysis services per month (20 years or older) | 22 | $7,836 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $6,953 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,656 | $171 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $2,871 | $239 |
| Dialysis services, per day, less than full month service (20 years or older) | 19 | $2,503 | $7 |
| Dialysis procedure including 1 evaluation | 11 | $2,169 | $72 |
| Return visit (30+ min) | 19 | $2,055 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,618 | $116 |
| Return visit (30+ min) | 21 | $1,391 | $66 |
2017: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 27 | $9,552 | $239 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,342 | $61 |
| New patient visit (45+ min) | 21 | $2,937 | $140 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,309 | $115 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $1,743 | $7 |
| Hemodialysis procedure with physician evaluation | 13 | $1,331 | $60 |
Medicaid work
$5,561 in 2024
Medicaid paid $5,561 for 202 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 175 | $4,477 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 27 | $1,084 |
| 2024 | 202 | 2 | 27 | $5,561 |
| 2023 | 103 | 2 | 16 | $4,724 |
| 2022 | 88 | 1 | 22 | $4,801 |
| 2021 | 29 | 1 | 16 | $1,868 |
| 2020 | 43 | 2 | 16 | $3,931 |
| 2019 | 74 | 2 | 29 | $7,534 |
| 2018 | 49 | 1 | 18 | $2,330 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 88 | $4,353 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 15 | $372 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 88 | $4,801 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 29 | $1,868 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 30 | $3,377 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 13 | $554 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 59 | $6,452 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 15 | $1,081 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 49 | $2,330 |
Drugs they prescribed that Part D paid
$17,364
Pharmacies billed $17,364 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 121) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
110 generic and 11 brand-name prescriptions · $17,364 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Losartan | 31 | $137 | $4 |
| Cinacalcet | 13 | $100 | $8 |
Year by year
| 2024 | 121 | 41 | 0% (0) | 9% | $17,364 |
| 2023 | 194 | 60 | 0% (0) | 15% | $41,678 |
| 2022 | 342 | 87 | 0% (0) | 13% | $37,346 |
| 2021 | 250 | 68 | 0% (0) | 17% | $29,646 |
| 2020 | 260 | 65 | 0% (0) | 12% | $16,075 |
| 2019 | 375 | 80 | None | 17% | $37,443 |
| 2018 | 222 | 57 | None | 27% | $37,499 |
| 2017 | 131 | 33 | 0% (0) | 14% | $7,435 |
| 2016 | 51 | 15 | 0% (0) | None | $3,023 |
| 2015 | 18 | None | 0% (0) | None | $555 |
| 2014 | 523 | 51 | None | 17% | $24,461 |
| 2013 | 788 | 79 | None | None | $38,720 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Sevelamer Carbonate | 20 | $9,592 | $480 |
| Cinacalcet | 13 | $3,141 | $242 |
| Doxazosin Mesylate | 13 | $321 | $25 |
| Calcitriol | 14 | $297 | $21 |
| Furosemide | 29 | $202 | $7 |
| Amlodipine Besylate | 15 | $114 | $8 |
2022: 8 drugs
| Lokelma | 13 | $5,993 | $461 |
| Sevelamer Carbonate | 20 | $5,284 | $264 |
| Cinacalcet | 17 | $2,617 | $154 |
| Calcitriol | 58 | $1,080 | $19 |
| Doxazosin Mesylate | 31 | $539 | $17 |
| Furosemide | 56 | $272 | $5 |
| Amlodipine Besylate | 15 | $110 | $7 |
| Lisinopril | 14 | $61 | $4 |
2021: 4 drugs
| Calcium Acetate | 20 | $1,741 | $87 |
| Calcitriol | 55 | $714 | $13 |
| Furosemide | 34 | $171 | $5 |
| Lisinopril | 19 | $110 | $6 |
2020: 5 drugs
| Calcium Acetate | 23 | $3,442 | $150 |
| Calcitriol | 63 | $849 | $13 |
| Furosemide | 19 | $170 | $9 |
| Losartan | 16 | $138 | $9 |
| Lisinopril | 18 | $80 | $4 |
2019: 10 drugs
| Sevelamer Carbonate | 21 | $10,389 | $495 |
| Renvela | 12 | $6,990 | $583 |
| Clinisol | 52 | $3,356 | $65 |
| Calcium Acetate | 14 | $1,037 | $74 |
| Calcitriol | 48 | $755 | $16 |
| Torsemide | 11 | $268 | $24 |
| Losartan | 35 | $247 | $7 |
| Furosemide | 46 | $231 | $5 |
| Tamsulosin | 11 | $116 | $11 |
| Lisinopril | 14 | $63 | $4 |
2018: 4 drugs
| Prosol | 18 | $2,456 | $136 |
| Calcitriol | 18 | $293 | $16 |
| Furosemide | 24 | $121 | $5 |
| Lisinopril | 18 | $98 | $5 |
2017: 3 drugs
| Calcitriol | 20 | $450 | $22 |
| Chlorthalidone | 13 | $363 | $28 |
| Amlodipine Besylate | 26 | $51 | $2 |
2016: 1 drug
| Chlorthalidone | 17 | $283 | $17 |
2014: 13 drugs
| Humalog | 12 | $2,923 | $244 |
| Atorvastatin | 59 | $598 | $10 |
| Metoprolol | 14 | $430 | $31 |
| Lisinopril | 60 | $281 | $5 |
| Omeprazole | 26 | $275 | $11 |
| Carvedilol | 24 | $199 | $8 |
| Metformin | 23 | $188 | $8 |
| Pravastatin | 11 | $187 | $17 |
| Amlodipine Besylate | 28 | $172 | $6 |
| Hydrochlorothiazide | 25 | $168 | $7 |
| Tamsulosin | 14 | $163 | $12 |
| Alendronate | 15 | $91 | $6 |
| Furosemide | 26 | $77 | $3 |
2013: 18 drugs
| Advair Diskus | 13 | $3,493 | $269 |
| Pioglitazone | 12 | $1,765 | $147 |
| Atorvastatin | 62 | $1,096 | $18 |
| Metoprolol | 17 | $587 | $35 |
| Omeprazole | 46 | $539 | $12 |
| Gabapentin | 17 | $429 | $25 |
| Lisinopril | 71 | $362 | $5 |
| Metformin | 53 | $327 | $6 |
| Carvedilol | 35 | $323 | $9 |
| Pravastatin | 24 | $280 | $12 |
| Tamsulosin | 21 | $251 | $12 |
| Amlodipine Besylate | 39 | $229 | $6 |
| Hydrochlorothiazide | 44 | $219 | $5 |
| Potassium Chloride | 11 | $165 | $15 |
| Metoprolol | 18 | $122 | $7 |
| Alendronate | 17 | $120 | $7 |
| Furosemide | 27 | $96 | $4 |
| Naproxen | 15 | $84 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1255624045
- Licence
- CA C182785California C182785: Current · expires 2026-10-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-05-26
- NPI last updated
- 2024-04-23
- NPI record certified
- 2024-04-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: University of Connecticut 263 Farmington Ave, Farmington, CT, 06030
This office lists an electronic records connection.